Aetna Foundation Announces $1 Million in Grants to Boys & Girls Clubs in Providence and Hartford

Top of the article

New funding across five years will support programs designed to promote healthier lifestyles for youth under the age of 18

WOONSOCKET, R.I. As part of its commitment to building healthier communities, the Aetna Foundation today announced it will be donating a total of $1 million to the Boys & Girls Clubs of Providence and Hartford. Both locations will receive $500,000 over the next five years.

The new funding from the Aetna Foundation, a private foundation affiliated with CVS Health, will help the Boys & Girls Clubs to reach hundreds of additional young people through innovative and effective programming. The grants will support programs that are focused on preventing underage substance misuse, including tobacco and vaping products, while also providing guidance on how to improve the overall health of youth in these communities.

"We know how important it is to teach healthy behaviors from a young age in order to ensure that young people have the tools and refusal skills they need to stay away from harmful habits like smoking," said Dr. Garth Graham, Vice President, Community Health & Impact, CVS Health and President, Aetna Foundation. "We believe the Boys & Girls Clubs of Providence and Hartford are uniquely equipped to help us evaluate the best approaches to educate young people about the dangers of substance misuse and teach healthy lifestyle choices. From there, we'll aim to replicate the successful approaches across other relationships and geographies."

The majority of the funding will help deliver "Positive Action" - a nationally acclaimed prevention program originally developed through partnerships between prevention specialists and Boys & Girls Clubs around the country to more young people in these communities. Participants in the "Positive Action" program are exposed to a variety of activities designed to hone their decision-making and critical thinking skills and help them learn how to avoid and resist alcohol, tobacco, other drugs, and premature sexual activity.

"Positive Action is a comprehensive strategy that helps young people better navigate the challenging path from childhood to adulthood," said Nicole Dufresne, CEO, Boys & Girls Clubs of Providence. "We are confident that the youth and teens who participate in this program will be armed with the crucial knowledge needed to lead a healthy lifestyle and have a great future. And we truly appreciate the support from both the CVS Health Foundation and Aetna Foundation, who have consistently been great community partners to us over the years."

These grants are part of CVS Health's commitment to help deliver the first tobacco-free generation. Through Be The First, the company and its foundations have committed to invest $50 million over five years to help deliver the first tobacco-free generation. These grants support efforts around healthy behavior programming for young people to ensure they have the tools and refusal skills they need to lead the healthiest lifestyle.

These grants also celebrate the long-standing commitment Boys & Girls Clubs have on helping our youth to be the best that they can be. The Boys & Girls Clubs of Providence is the longest continuously operating Boys & Girls Club in the country and the Boys & Girls Clubs of Hartford were the first ever Clubs to be formed. In addition to previous grants to the Boys & Girls Clubs in Hartford and Providence, CVS Health and Aetna colleagues regularly volunteer at locations throughout the home states of Rhode Island and Connecticut. The hundreds of colleague volunteer hours support large-scale annual events for the Boys & Girls Clubs in Hartford and Providence, as well as day-to-day interaction with young people participating in programs at these locations.

About the Aetna Foundation

The Aetna Foundation is an independent charitable and philanthropic affiliate of CVS Health (NYSE: CVS). As a national health foundation, the Aetna Foundation promotes wellness, health and access to high-quality health care for everyone. This work is enhanced by the time and commitment of Aetna employees, who volunteered 670,000 hours in 2018 alone. For more information, visit www.aetnafoundation.org.

Media Contacts

Erin Britt
401-770-9237
erin.britt@cvshealth.com

Ethan Slavin
860-273-6095
slavine@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

CVS Health Announces Successful First Year of Aetna Integration at One Year Anniversary

Top of the article

New Offerings Demonstrate Power and Potential of Combined Company

Leadership Focused on Being at Forefront of Health Care Transformation

WOONSOCKET, R.I. CVS Health Corporation (NYSE: CVS) today announced it has successfully completed the first year of combined operations following the acquisition of Aetna in late 2018. The combined company has met or exceeded its first-year integration goals while introducing new, consumer-focused offerings as a result of its unmatched capabilities. CVS Health remains on track to meet its most recent 2019 net synergy guidance and remains confident in its net synergy targets for 2020 and 2021.

"A full year of integration is a significant milestone in our long-term strategy to create the world's most consumer-centric health company," said Larry J. Merlo, President and CEO, CVS Health. "We're already seeing the benefits of our differentiated business model, which is delivering value to customers and patients across the country. I'm incredibly proud of the progress we've made, and I'm confident we will continue to raise the bar on what's possible in 2020."

CVS Health has been focused on four enterprise priorities to accelerate growth, as outlined at its Investor Day in June:

  • Growing and differentiating its businesses;
  • Delivering transformational products and services;
  • Creating a consumer-centric technology infrastructure; and
  • Modernizing enterprise functions and capabilities.

Merlo continued, "By executing on our strategy we've been able to develop and implement unique offerings that are resonating with consumers. Our HealthHUB model, which launched in Houston this year and will expand to a projected 1,500 locations by the end of 2021, has already shown an ability to improve patient outcomes and enhance customer satisfaction. We've also invested in a suite of in-home and digital offerings to better meet consumers where they are, such as our home hemodialysis device which is the subject of a clinical trial to support a future request for FDA clearance, and new virtual health services available through the CVS Pharmacy app. What's good for consumer health will be good for business, and the early results back that up.

"The evolution of health care will accelerate in 2020, and we're extremely well-positioned to lead. The private sector, and CVS Health in particular, will be the engine that drives health care innovation next year and beyond."

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this press release that are forward-looking include information related to 2019 net synergy guidance and net synergy targets for 2020 and 2021, and information in Mr. Merlo's quoted statement. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission ("SEC") filings, including those set forth in the Risk Factors section and under the section entitled "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K and in our most recently filed Quarterly Report on Form 10-Q.

You are cautioned not to place undue reliance on CVS Health's forward-looking statements. These forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date.

Investor Contact

Valerie Haertel
CVS Health
401-770-4050
Valerie.Haertel@CVSHealth.com

Media Contact

T.J. Crawford
CVS Health
212-457-0583
CrawfordT2@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
Off

Why Building Trust is Key to Delivering Crucial Care to Pharmacy Patients

Bottom of the article
Close-up photograph of doctor holding patient’s hand.

CVS Health pharmacists are often called on to employ not only clinical services, but a fair amount of detective work as well. Patients often report that their diet, exercise, and medications are all in check, but if they’re not experiencing results to match, then it’s time to dig a little deeper.

Elderly or infirm patients can pose special challenges: They can be mistrustful of medical professionals, stuck in old habits, and might not even be physically able to visit their local CVS for prescription recommendations and tests. Often, all the pharmacist has to go on is phone consultations and lab results. And yet, often that’s enough to produce life-changing results.

Pharmacist Angela Stigliano realizes that building trust with patients is a necessary part of the job. She’s a clinical pharmacist for CVS Health’s Medication Therapy Management (MTM) service, and provides care to members over the phone or via video chat.

She shared a recent success story about a patient with diabetes that demonstrates why trust is so important. The percentage of Americans 65 and older with diabetes is high, at about 25.2 percent or 12.0 million seniors (diagnosed and undiagnosed).https://www.diabetes.org/resources/statistics/statistics-about-diabetes It is a disease that can be well-controlled with diet and lifestyle changes — but they’re not always easy to make and adhere to without a helping hand.

Asking the Right Questions to Get a Diabetes Patient Back on Track

In March 2018 Stigliano began working with Vicki, a woman in her sixties who reported having a stroke that had left her with mild physical impairments. Though she had a long history with diabetes and high cholesterol, her doctors were confident that she would make a full recovery.

In their initial phone call, Vicki insisted that she followed a strict diet and was very mobile, but given the precarious state of her health, that “didn’t make sense,” says Stigliano: She was gaining weight, her A1C was unstable, and she wasn’t taking her cholesterol medication as prescribed. These factors put her at risk not only for another stroke, but heart disease as well.

Through a series of thirty-minute phone calls every few months, Stigliano fostered a friendly relationship with Vicki.

“I would use phrasing like ‘Tell me about your diet these days,’ instead of saying, ‘Have you been dieting?’ This allowed her to tell me about her diet without the feeling I was searching for a ‘correct answer,’” she says. “It can be difficult to be forthcoming with a stranger about a sensitive topic like being overweight or unable to walk and care for yourself properly.”

These days, there’s a lot of confusion about what a “healthy diet” actually means. Vicki reported trying a keto diet, and skipping meals, both unwise choices for a diabetic.

“Purposely not eating enough can be just as unhealthy as eating fast food every day. Not having enough range in your diet can also become unhealthy as well,” says Stigliano. She recommends the easy-to-follow MyPlate tactic to patients like Vicki. “You’re not telling them what to eat and what not to eat, but to focus more on portion sizes; to look at their diet and their plate a little bit differently.”

A CVS Health clinical pharmacist shares a recent diabetes patient success story that demonstrates the importance of relationship-building in her work.
Tweet this

After several months, Stigliano was pleased to hear that Vicki had begun to be more honest with herself and her medical team. She compromised with her prescriber, and was put on a low-intensity statin three times a week. And, as Stigliano had gently suggested over the course of their interactions, she began a low-carb, high-protein diet, and increased her physical activity.

All of these changes started to pay off. Vicki’s A1C had been steadily improving due to her adjusting her insulin, but after taking the initiative to make lifestyle changes, she had lost approximately twenty-five pounds, reduced her A1C to consistent readings at or around 7 percent, and mentioned that her LDL cholesterol had come down by 100 points on her latest lab test. And she felt positive, healthy, and empowered.

“When we first started talking, Vicki was not in good spirits,” says Stigliano. “She was very upset about her stroke, and really down, very defeatist. But, after Vicki began to take control of her health, Stigliano says, “It sounded like I was speaking to a whole different person. She was excited to tell me about her lifestyle, the change in her as person. She ended our most recent phone call by saying, ‘I’ll talk to you soon. I need someone to stay on top of me!’”

To learn more about our enterprise-wide approach to diabetes management and care, visit our Managing Diabetes with CVS Health page.

To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off

Supporting the Fight Against HIV/AIDS

Bottom of the article

This World AIDS Day, CVS Health is recognizing the progress made in the fight against HIV/AIDS and is teaming up with the U.S. Department of Health and Human Services (HHS) to help further reduce the spread of the HIV virus.

Reducing transmission of HIV

Currently, there are an estimated 1.1 million people in the U.S. living with HIV, and approximately 38,000 people diagnosed annually. Scientific advances over the past few decades have changed the paradigm for the prevention and treatment of the disease. For example, an HIV diagnosis is no longer a death sentence and can now be effectively managed through maintenance medications. In addition, more recent medical breakthroughs have brought to market pre-exposure prophylaxis (PrEP) medications that can prevent at-risk populations, including those who could contract the virus through sexual contact or drug use, from ever getting HIV.

HHS estimates that more than one million people in the U.S. could benefit from taking PrEP medication, however only 100,000 actually have a prescription. That is why CVS Health is teaming up with HHS to help make PrEP medication more accessible and affordable through a new HHS program called Ready, Set, PrEP, which is a key component of the Ending the HIV Epidemic In America initiative, which aims to reduce the number of new HIV infections in the U.S. by 90 percent over the next 10 years.

How it works

The HHS Ready, Set, PrEP program provides at-risk and HIV-negative individuals who do not have prescription drug coverage access to PrEP medication at no cost.  In addition, the program is providing education and awareness materials to help individuals gain more information about PrEP and learn how to access the Ready, Set, PrEP program. Once approved, and with a valid PrEP prescription from a health care provider, individuals can fill the medication at a participating pharmacy, including CVS Pharmacy and CVS Pharmacy Specialty Services locations or by mail. CVS Health has donated prescription dispensing services to HHS as part of Ready, Set, PrEP program. Those interested can learn more about Ready, Set, PrEP and apply online at GetYourPrep.com or calling toll-free 855-447-8410.

CVS Health has donated prescription dispensing services to HHS as part of Ready, Set, PrEP program. Those interested can learn more about Ready, Set, PrEP and apply online at GetYourPrep.com.
Tweet this

Our enterprise commitment

This is one more way that CVS Health is working to prevent the spread of HIV and help those living with HIV better manage the virus and prevent disease progression.

This includes an ongoing partnership with the Centers for Disease Control and Prevention (CDC) to help Act Against AIDS, which brings mobile HIV screening and testing services to CVS Pharmacy locations throughout the country.

In addition, through the CVS Specialty HIV Care Management program, patients can receive whole-patient management and support from nurses specially trained in HIV care.Nurse support is available to CVS Caremark members whose plans including Accordant Care Management (including CareTeam Choice or CareTeam Advanced) Comprehensive, continuous care can help promote medication adherence, improve outcomes, and reduce overall health costs. Further, at several CVS Pharmacy Specialty Services locations in New York City, HIV patients can receive proactive outreach to improve adherence to and management of HIV medications. This includes face-to-face counseling and/or telephonic outreach for all new-to-therapy patients; refill reminders; and additional co-morbidity and financial support and assistance, as appropriate.

Across CVS Health, we help support the HIV/AIDS community every day. Through high-touch support, screening and care management services, we help those who are at at-risk for or living with HIV/AIDS on their path to better health.

For more information about CVS Health’s efforts to improve care across the nation, visit our News & Insights page and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off

CVS Health Teams Up with U.S. Department of Health and Human Services to Support the Fight Against HIV

Top of the article

New initiative makes preventative PrEP medications more accessible and affordable to uninsured populations

WOONSOCKET, R.I. — CVS Health today joins the U.S. Department of Health and Human Services (HHS) to support the fight against HIV, which coincides with the launch of a new HHS initiative called Ready, Set, PrEP, a critical component of the Ending the HIV Epidemic in America Initiative. With CVS Health as one of the first participating pharmacies donating medication dispensing services to HHS, the Ready, Set, PrEP program will provide pre-exposure prophylaxis (PrEP) medication at no cost to eligible individuals. In addition, Ready, Set, PrEP has launched a robust communication campaign aimed at educating individuals about PrEP and making them aware of this key program. HIV-negative individuals who are at-risk for contracting the virus but do not have prescription drug coverage may qualify for the Ready, Set, PrEP program, and if approved, can fill the medication at CVS Pharmacy and CVS Pharmacy Specialty Services locations or by mail with a valid prescription. Ready, Set, PrEP aims to reduce the number of new HIV infections in the U.S. by 90 percent over the next ten years.

According to the Centers for Disease Control and Prevention (CDC), 1.1 million people in the U.S. are currently living with HIV and there are approximately 38,000 new HIV cases annually. In addition, HHS estimates that more than 1 million people in the U.S. could benefit from taking PrEP medications that are highly effective in reducing an individual’s risk of acquiring HIV, but only a small fraction are currently prescribed. With 76% of the U.S. living within five miles of a CVS Pharmacy, this partnership greatly increases local access to the life-saving benefits of the medication.

“As a part of our enterprise commitment to help people on their path to better health, CVS Health is dedicated to improving the lives of those at-risk and those living with HIV and other chronic conditions,” said Kevin Hourican, Executive Vice President, CVS Health and President, CVS Pharmacy. “As a community health partner at the local level, a critical part of the role we play is leveraging our national network of neighborhood retail locations to do all we can to support proactive health and wellness in the communities we serve. Increasing access to PrEP medications for the under-insured is something we are honored to partner with HHS to help make a reality.”

While a multitude of social, economic and demographic factors impact HIV transmission rates throughout the U.S., data often shows low-income individuals, minorities (specifically African Americans and Hispanics/Latinos) and LGBTQ+ populations are among the most vulnerable to HIV. This initiative, in addition to programs like Project Health that bring free health screenings to neighborhoods around the country, is the latest example of CVS Health’s efforts to provide access to affordable health care services to underserved communities at the local level, building on the company’s commitment to non-discrimination, quality health care and respect for the dignity of all people, regardless of sexual orientation, race, sex, gender expression, socioeconomic status, disability or any other factor.

In addition to partnering on the Ready, Set, PrEP initiative, CVS Health also has an ongoing partnership with the CDC to help Act Against AIDS, by providing mobile HIV screening and testing services at CVS Pharmacy locations throughout the country. The CVS Specialty HIV Care Management program also helps HIV-positive patients receive comprehensive and continuous whole-patient management and support from nurses specially trained in HIV care. CVS Specialty HIV advocates also help support those living with the virus, and each year, sponsor various PRIDE celebrations and provide information at the events about CVS Health HIV testing and treatment services.

To qualify for Ready, Set, PrEP, individuals must test negative for HIV, have a valid PrEP prescription from a health care provider, and not have prescription drug coverage. From there, individuals can fill the medication at any pharmacy of choice, including CVS Pharmacy and CVS Pharmacy Specialty Services locations or by mail. To apply online, visit GetYourPrep.com or call toll-free 855-447-8410. Once approved and with a valid prescription, locate your nearest CVS Pharmacy, visit CVS.com/store-locator.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

William Durling
401-770-4029
William.Durling@cvshealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
7
Display Hero
Off

Centene and CVS Health Announce Agreement for CVS Health to Acquire IlliniCare Health

Top of the article

ST. LOUIS — Centene Corporation (NYSE: CNC) (“Centene”) and CVS Health (NYSE: CVS) announced today that, in connection with the previously announced merger agreement between Centene and WellCare Health Plans, Inc. (NYSE: WCG), Centene has entered into a definitive agreement under which CVS Health will acquire Centene’s Illinois health plan subsidiary, IlliniCare Health Plan, Inc. (“IlliniCare”). The transaction entails the sale of Centene’s Medicaid and Medicare Advantage lines of business in Illinois.

Centene will retain IlliniCare’s Medicare-Medicaid Alignment Initiative (“MMAI”) business and IlliniCare’s statewide YouthCare foster care contract, set to commence in February 2020. Centene’s Ambetter business in Illinois is not affected. The companies are committed to ensuring that there is a smooth transition for members.

“We are continuing to make progress towards completing our transaction with WellCare and the divestiture of our IlliniCare Health plan is the next step in that process,” said Michael F. Neidorff, Centene’s Chairman, President and Chief Executive Officer. “Our employees in Illinois have done an exceptional job serving our communities in the state. We are pleased to enter this agreement with CVS Health, under which these employees can continue helping members achieve better health outcomes while delivering benefits to providers. We will work closely with CVS Health to ensure a smooth transition of this business for members, employees and providers.”

“Expanding our Medicaid and Medicare Advantage presence in Illinois will allow us to serve more members with our proven holistic approach that addresses physical, behavioral and social determinants of care,” said Karen S. Lynch, Executive Vice President, CVS Health and President, Aetna. “We look forward to working with Centene on a seamless transition and developing a deeper relationship with the state and local providers.”

The closing of the transaction with CVS Health is subject to U.S. federal antitrust clearance, receipt of Illinois state regulatory approvals and other customary closing conditions, as well as the closing of the Centene – WellCare transaction.

As previously announced on March 27, 2019, Centene and WellCare agreed to combine in a transaction that will create a premier healthcare enterprise focused on government-sponsored healthcare programs and a leader in Medicaid, Medicare and the Health Insurance Marketplace. The combination has received approvals from insurance and health care departments from 26 states. Completion of the Centene – WellCare transaction remains subject to clearance under the Hart-Scott-Rodino Act, receipt of required state regulatory approvals and other customary closing conditions.

Centene and WellCare continue to expect that the Centene – WellCare transaction will be completed by the first half of 2020.

The financial terms of this transaction will not be disclosed and the impact to CVS Health earnings once closed is expected to be immaterial.

Additional information about the Centene – WellCare transaction can be found at centene-wellcare.com.

About Centene

Centene Corporation, a Fortune 100 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children’s Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long-Term Services and Supports (LTSS), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as “Part D”), dual eligible programs and programs with the U.S. Department of Defense. Centene also provides healthcare services to groups and individuals delivered through commercial health plans. Centene operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, commercial programs, home-based primary care services, life and health management, vision benefits management, pharmacy benefits management, specialty pharmacy and telehealth services.

Centene uses its investor relations website to publish important information about the company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene’s investor relations website, http://www.centene.com/investors.

About CVS Health

CVS Health is the nation’s premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

CVS Health
Erin Shields Britt
401-770-9237
erin.britt@cvshealth.com

Cautionary Statement on Forward-Looking Statements of Centene

All statements, other than statements of current or historical fact, contained in this communication are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as “believe,” “anticipate,” “plan,” “expect,” “estimate,” “intend,” “seek,” “target,” “goal,” “may,” “will,” “would,” “could,” “should,” “can,” “continue” and other similar words or expressions (and the negative thereof). In particular, these statements include, without limitation, statements about Centene’s future operating or financial performance, market opportunity, growth strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of Centene’s proposed acquisition of WellCare Health Plans, Inc. (the “WellCare Transaction”), Centene’s recent acquisition (the “Fidelis Care Transaction”) of substantially all the assets of New York State Catholic Health Plan, Inc., d/b/a Fidelis Care New York (“Fidelis Care”), investments and the adequacy of Centene’s available cash resources.

These forward-looking statements reflect Centene’s current views with respect to future events and are based on numerous assumptions and assessments made by us in light of Centene’s experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors Centene believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions.

All forward-looking statements included in this filing are based on information available to us on the date of this communication. Except as may be otherwise required by law, Centene undertakes no obligation to update or revise the forward-looking statements included in this communication, whether as a result of new information, future events or otherwise, after the date of this filing. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to, the following: (i) the risk that regulatory or other approvals required for the WellCare Transaction may be delayed or not obtained or are obtained subject to conditions that are not anticipated that could require the exertion of management’s time and Centene’s resources or otherwise have an adverse effect on Centene; (ii) the possibility that certain conditions to the consummation of the WellCare Transaction will not be satisfied or completed on a timely basis and accordingly the WellCare Transaction may not be consummated on a timely basis or at all; (iii) uncertainty as to the expected financial performance of the combined company following completion of the WellCare Transaction; (iv) the possibility that the expected synergies and value creation from the WellCare Transaction will not be realized, or will not be realized within the expected time period; (v) the exertion of management’s time and Centene’s resources, and other expenses incurred and business changes required, in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the WellCare Transaction; (vi) the risk that unexpected costs will be incurred in connection with the completion and/or integration of the WellCare Transaction or that the integration of WellCare will be more difficult or time consuming than expected; (vii) the risk that potential litigation in connection with the WellCare Transaction may affect the timing or occurrence of the WellCare Transaction or result in significant costs of defense, indemnification and liability; (viii) a downgrade of the credit rating of Centene’s indebtedness, which could give rise to an obligation to redeem existing indebtedness; (ix) unexpected costs, charges or expenses resulting from the WellCare Transaction; (x) the inability to retain key personnel; (xi) disruption from the announcement, pendency and/or completion of the WellCare Transaction, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; and (xii) the risk that, following the WellCare Transaction, the combined company may not be able to effectively manage its expanded operations.

Additional factors that may cause actual results to differ materially from projections, estimates, or other forward-looking statements include, but are not limited to, the following: (i) Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; (ii) competition; (iii) membership and revenue declines or unexpected trends; (iv) changes in healthcare practices, new technologies, and advances in medicine; (v) increased healthcare costs, (vi) changes in economic, political or market conditions; (vii) changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act, collectively referred to as the Affordable Care Act (“ACA”), and any regulations enacted thereunder that may result from changing political conditions or judicial actions, including the ultimate outcome of the District Court decision in “Texas v. United States of America” regarding the constitutionality of the ACA; (viii) rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting Centene’s government businesses; (ix) Centene’s ability to adequately price products on federally facilitated and state-based Health Insurance Marketplaces; (x) tax matters; (xi) disasters or major epidemics; (xii) the outcome of legal and regulatory proceedings; (xiii) changes in expected contract start dates; (xiv) provider, state, federal and other contract changes and timing of regulatory approval of contracts; (xv) the expiration, suspension, or termination of Centene’s contracts with federal or state governments (including but not limited to Medicaid, Medicare, TRICARE or other customers); (xvi) the difficulty of predicting the timing or outcome of pending or future litigation or government investigations; (xvii) challenges to Centene’s contract awards; (xviii) cyber-attacks or other privacy or data security incidents; (xix) the possibility that the expected synergies and value creation from acquired businesses, including, without limitation, the Fidelis Care Transaction, will not be realized, or will not be realized within the expected time period; (xx) the exertion of management’s time and Centene’s resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions, including the Fidelis Care Transaction; (xxi) disruption caused by significant completed and pending acquisitions, including, among others, the Fidelis Care Transaction, making it more difficult to maintain business and operational relationships; (xxii) the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions, including, among others, the Fidelis Care Transaction; (xxiii) changes in expected closing dates, estimated purchase price and accretion for acquisitions; (xxiv) the risk that acquired businesses, including Fidelis Care, will not be integrated successfully; (xxv) the risk that, following the Fidelis Care Transaction, Centene may not be able to effectively manage its expanded operations; (xxvi) restrictions and limitations in connection with Centene’s indebtedness; (xxvii) Centene’s ability to maintain the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; (xxviii) availability of debt and equity financing, on terms that are favorable to us; (xxxix) inflation; and (xxx) foreign currency fluctuations.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect Centene’s business operations, financial condition and results of operations, in Centene’s filings with the Securities and Exchange Commission (the “SEC”), including the registration statement on Form S-4 filed by Centene with the Securities and Exchange Commission on May 23, 2019 (the “Registration Statement”), and Centene’s Annual Report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, Centene cannot give assurances with respect to Centene’s future performance, including without limitation Centene’s ability to maintain adequate premium levels or Centene’s ability to control its future medical and selling, general and administrative costs.

Important Additional Information and Where to Find It

In connection with the WellCare Transaction, on May 23, 2019, Centene filed with the SEC the Registration Statement, which included a prospectus with respect to the shares of Centene’s common stock to be issued in the WellCare Transaction and a joint proxy statement for Centene’s and WellCare’s respective stockholders (the “Joint Proxy Statement”). The SEC declared the Registration Statement effective on May 23, 2019, and the Joint Proxy Statement was first mailed to stockholders of Centene and WellCare on or about May 24, 2019. Each of Centene and WellCare may file other documents regarding the WellCare Transaction with the SEC. This communication is not a substitute for the Registration Statement, the Joint Proxy Statement or any other document that Centene or WellCare may send to their respective stockholders in connection with the WellCare Transaction. INVESTORS AND SECURITY HOLDERS OF CENTENE AND WELLCARE ARE URGED TO READ THE REGISTRATION STATEMENT, THE JOINT PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CENTENE, WELLCARE, THE WELLCARE TRANSACTION AND RELATED MATTERS. Investors and security holders of Centene and WellCare are able to obtain free copies of the Registration Statement, the Joint Proxy Statement and other documents (including any amendments or supplements thereto) containing important information about Centene and WellCare through the website maintained by the SEC at www.sec.gov. Centene and WellCare make available free of charge at www.centene.com and www.ir.wellcare.com, respectively, copies of materials they file with, or furnish to, the SEC.

No Offer or Solicitation

This communication is for informational purposes only and does not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or an offer to buy or the solicitation of an offer to buy any securities, and there shall be no sale of securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

The Importance of Bringing Diabetes Care into the Community

Bottom of the article

This article was written by Dr. Dan Knecht, Vice President of Health Strategy & Innovation at CVS Health.

1.5 million: That’s the number of Americans who are diagnosed with diabetes each year. 327 billion: That was the total cost of diagnosed diabetes in the United States in 2017, according to the American Diabetes Association.

These are big numbers, but they don’t tell the whole story. In addition to my day job as Vice President of Health Strategy and Innovation at CVS Health, I practice as a physician at Mount Sinai West Hospital in New York City. During my weekend rotations, I see firsthand the very real and negative impacts of uncontrolled diabetes on my patients. Diabetes can cause vision loss, kidney failure and neuropathic pain, in addition to accelerating and worsening cardiovascular disease.

Thankfully, the news is not all bad. As the number of people diagnosed with diabetes rises, so are the resources and treatment options available to them.

CVS Health recently partnered with Morning Consult to better understand the needs of people living with diabetes and the providers who deliver diabetes care. What we heard from patients and doctors is a desire to:

  • Expand access to local care
  • Better manage and predict out-of-pocket costs
  • Provide additional lifestyle support in the form of nutrition, exercise and social services

In honor of Diabetes Awareness Month, I sat down with fellow diabetes experts Dr. Steve Edelman, M.D., founder and director of Taking Control of Your Diabetes, and Joy Pape, R.N., a nationally known family nurse practitioner and certified diabetes educator, to discuss how we can address some of these needs through real action.

Watch our full CVS Health Live discussion above.

Read Dr. Knecht’s full article on LinkedIn.

For more information about CVS Health’s efforts to improve care across the nation, visit our News & Insights page and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
3

Re-Training Providers to Achieve Proper Blood Pressure Measurement

Bottom of the article
A photo of a woman’s hand on a blood pressure cuff.

Getting your blood pressure checked is a familiar experience at the doctor’s office, but recent research suggests that it may not always be accurate.

According to the American Heart Association (AHA), nearly half of all U.S. adults have high blood pressure, which is a leading risk factor for heart attacks, strokes, and preventable death.  Accurate measurement of a patient’s blood pressure is vital to providing accurate diagnoses and quality care.https://www.ama-assn.org/system/files/2019-11/market-research-survey-bp-measurement.pdf

Given the importance of accurate blood pressure readings, clinical guidelines recommend that health care providers be periodically re-trained on proper BP measurement; however, recent market research conducted by the American Medical Association (AMA) and the AHA indicated this may not always be the case.

Based on this research, the AMA and AHA partnered with MinuteClinic, along with a leading health care organization and leading academic medical centers, to test a new e-learning module. The module, called Achieving Accuracy: BP Measurement, was designed to provide all front-line health care providers with access to consistent training on proper BP measurement and is now available for health care professionals through the AHA.

In the survey of more than two thousand health care providers, half of the physicians and physician assistants (PAs) who responded, and a third of nurse respondents, said they had not received BP measurement re-training since their initial training in school. However, there seems to be broad support among the survey respondents for BP refresher training, with three-quarters or more of the nurses, PAs, primary care providers and pharmacists surveyed noting that it should be required.

Some common BP measurement errors that can result in pushing a patient’s diagnosis from normal to elevated, include:

  • Taking a reading while a patient is sitting with their legs crossed, which can raise systolic pressure by 5 to 8 mm Hghttps://www.ncbi.nlm.nih.gov/pubmed/17496470

  • Using the wrong cuff size, which can raise systolic pressure by approximately 10 mm Hghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911816

“Being able to test this new BP measurement re-training module with our providers on the front lines reinforces our long-standing commitment to advancing heart health and providing high quality care for our patients,” said David Fairchild, M.D., Chief Medical Officer, MinuteClinic. “Our providers appreciated the opportunity to be involved in this effort and we look forward to integrating this training into our clinical standards moving forward.”

A photo of a woman’s hand on a blood pressure cuff.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
2

Fighting Pneumonia With a Toothbrush: New Program Is Yielding Results

Bottom of the article
A woman smiling with a toothbrush in front of her mouth.

A first-of-its-kind CVS Health initiative to combat hospital-acquired pneumonia through better oral health is improving outcomes and receiving rave reviews from patients. To date, the Rush to Brush program has reached more than 8,000 Aetna members scheduled for one of 23 types of inpatient surgery with kits containing high-quality oral care products, education and a personalized ‘get well’ card.
The effort is designed to help reduce the incidence of hospital-acquired pneumonia, one of the most common and life-threatening infections hospitalized patients can contract.

“We want to shift the paradigm around oral health in hospitals. It’s actually more important to take care of your teeth and mouth when you go in for surgery, not less,” said Mary Lee Conicella, DMD, Chief Dental Officer for Aetna.

Dr. Conicella noted that oral care is critically important in the post-operative setting because the mouth is filled with bacteria. One study found colonization by disease-causing bacteria — especially those linked to pneumonia — in 90 percent of patients within 72 hours of being admitted to the hospital. Those bacteria don’t just stay in the mouth, however; they are often inadvertently inhaled into the lungs.https://www.aha.org/2018-03-29-what-your-hospital-doing-about-1-hospital-acquired-infectionhttps://msphere.asm.org/content/1/4/e00199-16https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414413https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-016-0150-3

Brushing one’s teeth greatly reduces the population of bacteria in the mouth, according to nurse-researcher Dian Baker, Ph.D., professor at California State University, Sacramento.  “When patients brush their teeth, they’re basically taking their bacterial count from hundreds of millions down to just a few, and this greatly reduces their risk of pneumonia.”

Dr. Baker’s research inspired the Rush to Brush program, which is paying dividends in terms of clinical results, member satisfaction and reduced health care costs. To date, there has been about a 30 percent decrease in the incidence of pneumonia among members who received the Rush to Brush kit.Data based on early observations of pneumonia claims within 90 days of procedure for ~1,200 patients Additionally, estimates are that the program will yield approximately $75M in annual avoidable medical costs across Aetna’s commercial and Medicare business.

A note from a patient who took part in the Rush to Brush program.
A note from a patient who took part in the Rush to Brush program.

And members love it: Seventy percent took the kit with them to the hospital, and 95 percent have expressed positive feelings about the program and about Aetna. Members who received the kit have been effusive, saying the initiative “shows that Aetna is caring and considerate” and that “the fact that Aetna took a vested interested in my recovery meant so much.” One member noted that the kit “took the guess work out. All items were needed, all items were used — very important and useful.”

In addition to collaborating with Dr. Baker, Aetna worked with Johnson & Johnson and Colgate-Palmolive to outfit the kits with Colgate Total toothpaste, a high-quality toothbrush, Listerine Zero mouthwash and tips on good oral health.

The program illustrates unique ability of CVS Health and Aetna to use clinical and member data insights to unlock members’ health care needs, according to Daniel Knecht, M.D., Vice President of Health Strategy and Innovation for CVS Health. “Using those insights, we are then able to bring together the resources our members need on their road to recovery,” he added.

For more information about CVS Health’s efforts to improve care across the nation, visit our News & Insights page and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
3

How a Trusted Partnership Helped One Type 2 Patient Live Healthier

Bottom of the article
A photo of a scale on wooden floor.

When Regina Wu first met Kenneth, she asked him about his diet and exercise — as CVS Health pharmacists routinely do with their patients. Kenneth, a 77-year-old man with diabetes and a sweet tooth who once weighed 286 pounds, said he often drank a liter of soda per day.

Regina immediately sensed a red flag.

“I know that soda is something people can become addicted to in a way,” she says. “It’s caffeinated, high in sugar, and people start to crave a soda fix. And soda is a big problem for blood sugar control.”

Research shows drinking sugary beverages like soda every day could increase a person’s risk of developing type 2 diabetes by 26 percent. For those already diagnosed with type 2 diabetes, soda consumption can hamper their efforts to keep their blood sugar at an acceptable level.

That certainly was the case with Kenneth. He took his medications diligently, but his A1C reading was 10.1 percent. A normal A1C is less than 5.7 percent, and the goal for type 2 diabetes patients is to keep their A1C levels below 7 percent. Kenneth was struggling enough with his blood sugar that his doctor increased his insulin dosages.

Losing weight and changing eating habits can be challenging if the problem seems large and insurmountable. Regina saw an opportunity to focus on a small, manageable change: reduce Kenneth’s soda intake.

It’s these kinds of interactions that CVS Health had in mind when we created our Medication Therapy Management program. The program is designed to allow CVS pharmacists to engage one-on-one with patients, identifying any barriers in their treatment, recommending lifestyle changes, and creating an ongoing dialogue to ensure that patients are taking their medication and getting the follow-up care they need.

Regina and her colleagues frequently work with type 2 diabetes patients: Approximately 1 in 10 Americans — or about 30 million people — have type 2 diabetes, according to the Centers for Disease Control and Prevention. While the disease typically surfaces in people over age 45, young adults, teens and children are increasingly being diagnosed.

Regina spoke every few months with Kenneth, urging him to drink even just one less can of soda. Then, in 2018, Kenneth was hospitalized with an infection, and he was hospitalized a second time about a year later. After Kenneth came home from the hospital, he cut back to two Diet Cokes a day. By May 2019, his A1C reading was 8.6 percent, much closer to his target level, and he now weighs 240 pounds. He’s on a 50-gram-carbohydrates per day diet, walks more often, his blood pressure levels have improved and his medication dosages have been reduced. He has kicked the soda habit completely, and has become an advocate among his family members to minimize soda drinking.

“I see the pharmacist as part of the care engagement team,” Regina says. “It really takes a village and the pharmacist is someone patients can talk to in between doctor visits or after hospital discharge. They get to know me, I get to know them, and it becomes a friendship, and with that trust, we talk about how to make small changes that can add up.”

To learn more about our enterprise-wide approach to diabetes management and care, visit our Managing Diabetes with CVS Health page.

To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

A photo of a scale on wooden floor.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off